| Enhancer ID: | E_02_0663 |
| Species: | human |
| Position : | chr7:22723271-22725271 |
| Biosample name: | |
| Experiment class : | High+Lowthroughput |
| Enhancer type: | Enhancer |
| Disease: | Neurological disease |
| Pubmed ID: | 31368839 |
| Enhancer experiment: | PCR, flow cytometry |
| Enhancer experiment description: | The acute response was measured 6 h after ASO administration, via evaluation for increased plasma production of in_x0002_terleukin 6 (IL6), IL10, monocyte chemoattractant protein 1 (MCP-1) and macrophage inflammatory protein-1b(MIP-1b). |
| Target gene : | IL6,IL10 |
| Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
| Less strong evidence: | RNA-Seq |
| Target gene experiment description: | The acute response was measured 6 h after ASO administration, via evaluation for increased plasma production of in_x0002_terleukin 6 (IL6), IL10, monocyte chemoattractant protein 1 (MCP-1) and macrophage inflammatory protein-1b(MIP-1b).;The acute response was measured 6 h after ASO administration, via evaluation for increased plasma production of in_x0002_terleukin 6 (IL6), IL10, monocyte chemoattractant protein 1 (MCP-1) and macrophage inflammatory protein-1b(MIP-1b). |
| TF name : | -- |
| TF experiment: | PCR,????? |
| TF experiment description: | The acute response was measured 6 h after ASO administration, via evaluation for increased plasma production of in_x0002_terleukin 6 (IL6), IL10, monocyte chemoattractant protein 1 (MCP-1) and macrophage inflammatory protein-1b(MIP-1b).;The acute response was measured 6 h after ASO administration, via evaluation for increased plasma production of in_x0002_terleukin 6 (IL6), IL10, monocyte chemoattractant protein 1 (MCP-1) and macrophage inflammatory protein-1b(MIP-1b). |
| Enhancer function : | The acute response was measured 6 h after ASO administration, via evaluation for increased plasma production of in_x0002_terleukin 6 (IL6), IL10, monocyte chemoattractant protein 1 (MCP-1) and macrophage inflammatory protein-1b(MIP-1b). |
| Enhancer function experiment: | Immunohistochemical staining |
| Enhancer function experiment description: |
The acute response was measured 6 h after ASO administration, via evaluation for increased plasma production of in_x0002_terleukin 6 (IL6), IL10, monocyte chemoattractant protein 1 (MCP-1) and macrophage inflammatory protein-1b(MIP-1b). |
| SNP ID: | -- |
| GeneName | Pathway Name | Source | Gene Number |
|---|